Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna Stock on Track for Best Day Since 2022
10:10am, Thursday, 14'th Dec 2023
Moderna Inc (NASDAQ:MRNA) stock was last seen up 15.4% to trade at $90.72, one of the best stocks on the Nasdaq today, after data from a mid-stage trial showed the company's experimental cancer va
Moderna stock popped 15% on Thursday: explore why
09:29am, Thursday, 14'th Dec 2023
Moderna Inc (NASDAQ: MRNA) is up nearly 15% this morning after reporting mid-stage trial data for its experimental vaccine for skin cancer.
Moderna CEO Stephane Bancel on melanoma treatment development: A big day for patients
09:29am, Thursday, 14'th Dec 2023
Moderna CEO Stephane Bancel joins 'Squawk Box' to discuss new developments in the treatment for melanoma, after studies showed Moderna and Merck's experimental cancer vaccine, when used in combination
2 Big Stocks Making Big Moves Thursday
09:28am, Thursday, 14'th Dec 2023
Stocks continued to move higher following the Federal Reserve's latest decision. Adobe shares fell as strong financial results weren't enough to overcome worries about future growth.
Why Is Moderna (MRNA) Stock Up 11% Today?
09:26am, Thursday, 14'th Dec 2023
Moderna (NASDAQ: MRNA ) stock is rising thanks to positive results from the skin cancer vaccine developed alongside Merck (NYSE: MRK ). The big news here comes after a Phase 2b trial of mRNA-4157 as a
Moderna's stock rallies 7.9% after announcing positive data in trial of melanoma treatment combined with Merck's Keytruda
06:48am, Thursday, 14'th Dec 2023
Moderna Inc.'s stock MRNA, +0.72% soared 7% early Thursday, after the biotech and partner Merck MRK, +2.65% announced positive data from a mid-stage trial of Moderna's mRNA-4157 in combination with Me
Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
06:30am, Thursday, 14'th Dec 2023
Those results build on midstage trial data Moderna and Merck released earlier this year, which examined the efficacy of the combination over a shorter period.
Moderna Reports More Promising Data on Its Cancer Treatment
06:30am, Thursday, 14'th Dec 2023
Moderna's personalized cancer vaccine is being used with a Merck immunotherapy drug to fight melanoma cancer.
3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year
05:00am, Wednesday, 13'th Dec 2023
Stocks won't automatically become more expensive when we shift into a new year. But those that have struggled this year and have strong long-term outlooks could rebound at any point.
Moderna (MRNA), Merck Start 2nd Late-Study on Cancer Therapy
03:02pm, Tuesday, 12'th Dec 2023
The second late-stage study will evaluate Moderna (MRNA)/Merck's investigational cancer combination therapy in certain lung cancer patients. A late-stage study in melanoma indication is ongoing.
Moderna reorganizes to sharpen focus on vaccine sales, chief commercial officer to leave company
08:19am, Tuesday, 12'th Dec 2023
Moderna Inc. MRNA, +2.09% on Tuesday announced a reorganization designed to sharpen the company's focus on driving sales of COVID vaccine Spikevax and on the expected 2024 launch of a vaccine for resp
Moderna, Merck begin late-stage study for mRNA cancer therapy
07:01am, Monday, 11'th Dec 2023
Moderna and Merck & Co said on Monday they have started a late-stage trial of their experimental personalized mRNA cancer treatment in combination with blockbuster drug Keytruda for patients with a ty
Moderna, Inc. (MRNA) 2023 ESG Day Conference (Transcript)
02:54pm, Thursday, 07'th Dec 2023
Moderna, Inc. (NASDAQ:MRNA ) 2023 ESG Day Conference Call December 7, 2023 8:00 AM ET Company Participants Lavina Talukdar - Head of Investor Relations Stéphane Bancel - Chief Executive Officer Kyle
Moderna cancer vaccine data expected to deliver only modest upside
03:54pm, Wednesday, 06'th Dec 2023
Moderna Therapeutics Inc (NASDAQ:MRNA)'s upcoming update on its cancer vaccine trial in patients with adjuvant melanoma will only prompt a modest positive stock reaction, according to analysts at Jeff
3 Dirt Cheap Stocks You'll Regret Not Buying Before the New Year
06:00am, Monday, 04'th Dec 2023
Carnival and Apple both have climbed this year -- but they still have plenty of room to run thanks to customer demand. Investors have shied away from Moderna as vaccine demand falls, but a new wave of
